Report Detail
Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Report 2019
- RnM2786195 |
- 22 January, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
The global Ventilator Associated Pneumonia (VAP) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Ventilator Associated Pneumonia (VAP) Therapeutics market status and forecast, categorizes the global Ventilator Associated Pneumonia (VAP) Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Major manufacturers covered in this report
Achaogen Inc
Adenium Biotech ApS
Aridis Pharmaceuticals LLC
AstraZeneca Plc
Bayer AG
Cardeas Pharma Corp
Destiny Pharma Ltd
Dong-A Socio Holdings Co Ltd
Lakewood-Amedex Inc
MedImmune LLC
Meiji Seika Pharma Co Ltd
Merck & Co Inc
Motif Bio Plc
Nabriva Therapeutics AG
Polyphor Ltd
Shionogi & Co Ltd
Tetraphase Pharmaceuticals Inc
The Medicines Company
Theravance Biopharma Inc
Wockhardt Ltd
Zavante Therapeutics Inc
In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Segment by Type
Prevention
Physiotherapy
Immunity Therapy
Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Table of Contents
Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Report 2019
1 Ventilator Associated Pneumonia (VAP) Therapeutics Market Overview
- 1.1 Ventilator Associated Pneumonia (VAP) TherapeuticsProduct Overview
- 1.2 Ventilator Associated Pneumonia (VAP) Therapeutics Segment by Type
- 1.2.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Comparison by Types (2014-2025)
- 1.2.2 Prevention
- 1.2.3 Physiotherapy
- 1.2.4 Immunity Therapy
- 1.3 Ventilator Associated Pneumonia (VAP) Therapeutics Segment by Application
- 1.3.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Comparison by Application (2014-2025)
- 1.3.1 Hospitals
- 1.3.2 Ambulatory Surgical Center
- 1.3.3 Diagnostic Centers
- 1.4 Ventilator Associated Pneumonia (VAP) Therapeutics Market by Region
- 1.4.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Comparison by Region (2014-2025)
- 1.4.2 United States Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2014-2025)
- 1.4.3 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2014-2025)
- 1.4.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2014-2025)
- 1.4.5 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2014-2025)
- 1.4.7 India Ventilator Associated Pneumonia (VAP) Therapeutics Status and Prospect (2014-2025)
- 1.5 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Revenue (2014-2025)
- 1.5.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Growth Rate (2014-2025)
- 1.5.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue and Growth Rate (2014-2025)
2 Ventilator Associated Pneumonia (VAP) Therapeutics by Company, Region, Type and Application
- 2.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Market Competition by Companies
- 2.1.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share of Key Companies (2014-2019)
- 2.1.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share by Company (2014-2019)
- 2.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Revenue by Region
- 2.2.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Region (2014-2019)
- 2.2.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share by Region (2014-2019)
- 2.3 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Revenue by Type
- 2.3.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Type (2014-2019)
- 2.3.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Market Share by Type (2014-2019)
- 2.4 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales by Application
3 United States Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue and Price
- 3.1 United States Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Revenue (2014-2019)
- 3.1.1 United States Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (2014-2019)
- 3.1.2 United States Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Rate (2014-2019)
- 3.1.3 United States Ventilator Associated Pneumonia (VAP) Therapeutics Price Trend (2014-2019)
- 3.2 United States Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Company
- 3.3 United States Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Type
- 3.4 United States Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Application
4 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue and Price
- 4.1 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Value (2014-2019)
- 4.1.1 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (2014-2019)
- 4.1.2 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Rate (2014-2019)
- 4.1.3 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Price Trend (2014-2019)
- 4.2 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Company
- 4.3 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Type
- 4.4 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Application
5 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue and Price
- 5.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Revenue (2014-2019)
- 5.1.1 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (2014-2019)
- 5.1.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Rate (2014-2019)
- 5.1.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Price Trend (2014-2019)
- 5.2 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Company
- 5.3 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Type
- 5.4 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Application
6 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue and Price
- 6.1 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Value (2014-2019)
- 6.1.1 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (2014-2019)
- 6.1.2 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Rate (2014-2019)
- 6.1.3 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Price Trend (2014-2019)
- 6.2 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Company
- 6.3 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Type
- 6.4 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Application
7 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue and Price
- 7.1 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Value (2014-2019)
- 7.1.1 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (2014-2019)
- 7.1.2 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Rate (2014-2019)
- 7.1.3 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Price Trend (2014-2019)
- 7.2 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Company
- 7.3 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Type
- 7.4 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Application
8 India Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue and Price
- 8.1 India Ventilator Associated Pneumonia (VAP) Therapeutics Sales and Value (2014-2019)
- 8.1.1 India Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Rate (2014-2019)
- 8.1.2 India Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Rate (2014-2019)
- 8.1.3 India Ventilator Associated Pneumonia (VAP) Therapeutics Price Trend (2014-2019)
- 8.2 India Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Company
- 8.3 India Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Type
- 8.4 India Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Share by Application
9 Company Profiles and Key Figures in Ventilator Associated Pneumonia (VAP) Therapeutics Business
- 9.1 Achaogen Inc
- 9.1.1 Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.1.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.1.3 Achaogen Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.1.4 Main Business and Markets Served
- 9.2 Adenium Biotech ApS
- 9.2.1 Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.2.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.2.3 Adenium Biotech ApS Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.2.4 Main Business and Markets Served
- 9.3 Aridis Pharmaceuticals LLC
- 9.3.1 Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.3.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.3.3 Aridis Pharmaceuticals LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.3.4 Main Business and Markets Served
- 9.4 AstraZeneca Plc
- 9.4.1 AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.4.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.4.3 AstraZeneca Plc Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.4.4 Main Business and Markets Served
- 9.5 Bayer AG
- 9.5.1 Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.5.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.5.3 Bayer AG Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.5.4 Main Business and Markets Served
- 9.6 Cardeas Pharma Corp
- 9.6.1 Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.6.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.6.3 Cardeas Pharma Corp Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.6.4 Main Business and Markets Served
- 9.7 Destiny Pharma Ltd
- 9.7.1 Destiny Pharma Ltd Production Sites and Area Served
- 9.7.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.7.3 Destiny Pharma Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.7.4 Main Business and Markets Served
- 9.8 Dong-A Socio Holdings Co Ltd
- 9.8.1 Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.8.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.8.3 Dong-A Socio Holdings Co Ltd Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.8.4 Main Business and Markets Served
- 9.9 Lakewood-Amedex Inc
- 9.9.1 Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.9.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.9.3 Lakewood-Amedex Inc Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.9.4 Main Business and Markets Served
- 9.10 MedImmune LLC
- 9.10.1 MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Production Sites and Area Served
- 9.10.2 Ventilator Associated Pneumonia (VAP) Therapeutics Specification and Application
- 9.10.3 MedImmune LLC Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue, Price and Gross Margin (2014-2019)
- 9.10.4 Main Business and Markets Served
- 9.11 Meiji Seika Pharma Co Ltd
- 9.12 Merck & Co Inc
- 9.13 Motif Bio Plc
- 9.14 Nabriva Therapeutics AG
- 9.15 Polyphor Ltd
- 9.16 Shionogi & Co Ltd
- 9.17 Tetraphase Pharmaceuticals Inc
- 9.18 The Medicines Company
- 9.19 Theravance Biopharma Inc
- 9.20 Wockhardt Ltd
- 9.21 Zavante Therapeutics Inc
10 Ventilator Associated Pneumonia (VAP) Therapeutics Maufacturing Cost Analysis
- 10.1 Ventilator Associated Pneumonia (VAP) Therapeutics Key Raw Materials Analysis
- 10.1.1 Key Raw Materials
- 10.1.2 Key Raw Materials Price Trend
- 10.1.3 Key Suppliers of Raw Materials
- 10.2 Proportion of Manufacturing Cost Structure
- 10.3 Manufacturing Process Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics
- 10.4 Ventilator Associated Pneumonia (VAP) Therapeutics Industrial Chain Analysis
11 Marketing Channel, Distributors and Customers
- 11.1 Marketing Channel
- 11.1.1 Direct Marketing
- 11.1.2 Indirect Marketing
- 11.2 Ventilator Associated Pneumonia (VAP) Therapeutics Distributors List
- 11.3 Ventilator Associated Pneumonia (VAP) Therapeutics Customers
12 Market Dynamics
- 12.1 Market Trends
- 12.2 Opportunities
- 12.3 Market Drivers
- 12.4 Challenges
- 12.5 Influence Factors
13 Ventilator Associated Pneumonia (VAP) Therapeutics Market Forecast
- 13.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue and Price Forecast
- 13.1.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Forecast (2019-2025)
- 13.1.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Forecast (2019-2025)
- 13.1.3 Global Ventilator Associated Pneumonia (VAP) Therapeutics Price Trend Forecast (2019-2025)
- 13.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Forecast by Region
- 13.2.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Growth Forecast by Region (2019-2025)
- 13.2.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Growth Forecast by Region (2019-2025)
- 13.2.3 United States Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue Growth Forecast (2019-2025)
- 13.2.4 Europe Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue Growth Forecast (2019-2025)
- 13.2.5 China Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue Growth Forecast (2019-2025)
- 13.2.6 Japan Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue Growth Forecast (2019-2025)
- 13.2.7 Southeast Asia Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue Growth Forecast (2019-2025)
- 13.2.8 India Ventilator Associated Pneumonia (VAP) Therapeutics Sales, Revenue Growth Forecast (2019-2025)
- 13.3 Global Ventilator Associated Pneumonia (VAP) Therapeutics Forecast by Type
- 13.3.1 Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Forecast by Type (2019-2025)
- 13.3.2 Global Ventilator Associated Pneumonia (VAP) Therapeutics Revenue Forecast by Type (2019-2025)
- 13.3.3 Global Ventilator Associated Pneumonia (VAP) Therapeutics Price Forecast by Type (2019-2025)
- 13.4 Global Ventilator Associated Pneumonia (VAP) Therapeutics Forecast by Application
14 Research Findings and Conclusion
15 Methodology and Data Source
- 15.1 Methodology/Research Approach
- 15.1.1 Research Programs/Design
- 15.1.2 Market Size Estimation
- 15.1.3 Market Breakdown and Data Triangulation
- 15.2 Data Source
- 15.2.1 Secondary Sources
- 15.2.2 Primary Sources
- 15.3 Author List
Summary:
Get latest Market Research Reports on Ventilator Associated Pneumonia (VAP) Therapeutics. Industry analysis & Market Report on Ventilator Associated Pneumonia (VAP) Therapeutics is a syndicated market report, published as Global Ventilator Associated Pneumonia (VAP) Therapeutics Sales Market Report 2019. It is complete Research Study and Industry Analysis of Ventilator Associated Pneumonia (VAP) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
